Evidence map›Paper›PMID 28474051›Full record

ArticlePublic health research & practice2017

Should tobacco and alcohol companies be allowed to influence Australia's National Drug Strategy?

Becky Freeman, Ross MacKenzie, Mike Daube

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Public health research & practice, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Becky FreemanSchool of Public Health, University of Sydney, NSW, Australia, becky.freeman@sydney.edu.au.
Ross MacKenzieDepartment of Psychology, Macquarie University, Sydney, NSW, Australia.
Mike DaubePublic Health Advocacy Institute, Curtin University, Perth, Western Australia.
Curtin University · AUMacquarie University · AUUniversity of Sydney · AU

Funding

Tobacco Companies, Public Policy and Global HealthR01CA091021 · NCI · U OF L LONDON SCH/HYGIENE &TROPICAL MED · PI LEE, KELLEY · 2001 to 2018
$5.1M
NCI NIH HHS R01 CA091021
6 · The paper itself

Abstract

Formation of Australia's National Drug Strategy (NDS) included an extensive consultation process that was open not only to community and public health stakeholders, but also to representatives of the tobacco and alcohol industries. Australia is bound by the World Health Organization Framework Convention on Tobacco Control, which requires governments to protect tobacco control measures from interference by the tobacco industry. NDS consultation submissions made by these conflicted industries are not publicly available for scrutiny. The NDS goals are at odds with the commercial agenda of industries that support regulatory stagnation, oppose and undermine effective action, ignore and distort evidence, and prioritise profits over health.

Indexed as

Alcoholic BeveragesFood IndustryHealth PolicySmoking PreventionTobacco IndustryAlcoholismAustraliaHumans

Identifiers

PMID28474051
PMCPMC5687808
OpenAlexW2608462819

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.